What's Happening?
Haleon, a consumer health company, has announced a significant investment in India, aiming to expand its reach in one of its fastest-growing markets. The company plans to invest approximately £175 million to build a new oral health manufacturing site
in Madhya Pradesh, central India. This initiative is part of Haleon's strategy to reach one billion more consumers by 2030. The new facility will enhance the company's supply chain capabilities and support its distribution efforts across rural India, where access to dental care is limited. The investment will also create up to 500 jobs and is expected to open in early 2028, with supply commencing the following year.
Why It's Important?
This investment by Haleon underscores the growing importance of the Indian market in the global consumer health sector. By focusing on rural areas, where dental care access is scarce, Haleon aims to address significant unmet health needs. The initiative aligns with a broader trend towards prevention and self-care, as India's consumer health market is projected to reach over £23 billion by 2030. The expansion will not only boost Haleon's market presence but also contribute to local economic development by creating jobs and enhancing healthcare access in underserved communities.
What's Next?
Haleon's new manufacturing site is expected to become operational by early 2028, with distribution starting the following year. The company plans to double its 'last-mile' reach in rural areas, employing frontline teams equipped with diagnostic tools to educate and provide access to oral health products. This strategic move is likely to influence other consumer health companies to invest in similar markets, potentially leading to increased competition and innovation in the sector.
